Consoli Leo, Nino Gonzalez Francisco Javier, Bartolozzi Henri, Ali Namira Mohammed, Fagbamila Oluwaseun, Baudo Massimo
Faculty of Medicine, Federal University of Bahia, Salvador, 40140330, Brazil.
University of Deusto, School of Medicine, Bilbao, 48007, Spain.
Interdiscip Cardiovasc Thorac Surg. 2025 Aug 5;40(8). doi: 10.1093/icvts/ivaf178.
A minimally invasive approach by a right mini-thoracotomy has been developed for surgical ablation of atrial fibrillation. However, the efficacy and safety compared to a median sternotomy remains unclear.
We searched PubMed, Embase, and the Cochrane Library for eligible studies. Meta-analysis was performed for primary (recurrence of atrial tachyarrhythmias at 1 and 2 years) and secondary (hospital and ICU stay, adverse events, 30-day mortality, cardiopulmonary bypass, and aortic cross-clamp time) end-points. We compared end-points using risk ratio (RR) for binary outcomes and mean difference (MD) for continuous ones. We calculated 95% confidence intervals (CI) and used the random-effects model for all outcomes. We performed subgroup analysis for the main outcome based on lesion set, energy source, type of surgery, and propensity score matching.
We included 12 observational studies (n = 3122). No difference was found for the primary outcome at 1 (RR 0.8; [95% CI]: 0.62-1.03; P = 0.08) and 2 years (RR 0.9; [95% CI]: 0.74-1.13; P = 0.4). The thoracotomy group had lower complications (RR 0.72; [95% CI]: 0.55-0.97; P = 0.016), 30-day mortality (OR 0.26; [95% CI]: 0.10-0.70; P = 0.007), hospital stay (MD -5.35; [95% CI]: -7.94 to 2.77; P < 0.001), and ICU stay (MD -2.21; [95% CI]: -3.02 to 1.40; P < 0.001). Cardiopulmonary bypass and aortic clamping time were significantly higher in the thoracotomy group.
This meta-analysis found that surgical ablation by a mini-thoracotomy might achieve similar rhythm control to a median sternotomy while possibly improving safety and promoting faster recovery. However, conclusions are limited by the observational nature of the evidence and randomized trials are warranted.
已经开发出一种通过右胸小切口的微创方法用于房颤的手术消融。然而,与正中开胸手术相比,其疗效和安全性仍不明确。
我们在PubMed、Embase和Cochrane图书馆中检索符合条件的研究。对主要终点(1年和2年时房性快速心律失常的复发)和次要终点(住院和重症监护病房停留时间、不良事件、30天死亡率、体外循环和主动脉阻断时间)进行荟萃分析。对于二元结局,我们使用风险比(RR)比较终点;对于连续结局,我们使用平均差(MD)。我们计算95%置信区间(CI),并对所有结局使用随机效应模型。我们根据病变集、能量来源、手术类型和倾向评分匹配对主要结局进行亚组分析。
我们纳入了12项观察性研究(n = 3122)。在1年(RR 0.8;[95% CI]:0.62 - 1.03;P = 0.08)和2年时(RR 0.9;[95% CI]:0.74 - 1.13;P = 0.4)的主要结局未发现差异。开胸手术组的并发症(RR 0.72;[95% CI]:0.55 - 0.97;P = 0.016)、30天死亡率(OR 0.26;[95% CI]:0.10 - 0.70;P = 0.007)、住院时间(MD -5.35;[95% CI]:-7.94至2.77;P < 0.001)和重症监护病房停留时间(MD -2.21;[95% CI]:-3.02至1.40;P < 0.001)较低。开胸手术组的体外循环和主动脉阻断时间显著更长。
这项荟萃分析发现,通过小切口进行手术消融可能与正中开胸手术实现相似的节律控制,同时可能提高安全性并促进更快恢复。然而,结论受到证据观察性质的限制,需要进行随机试验。